Hybrigenics SA (ALHYG) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Summary

Hybrigenics SA (Hybrigenics) is a biopharmaceutical company that develops new targets and therapies against proliferative and non-cancerous diseases. Its lead product candidate Inecalcitol, is a vitamin D receptor agonist being assessed for various cancer indications including prostate cancer, chronic lymphocytic leukaemia and moderate to severe psoriasis. The company is also investigating the action of deubiquitinating enzymes (DUB) in the recycling of onco-proteins and the utility of proprietary patented DUB inhibitors against various cancer indications. Hybrigenics employs its expertise in DUBs to discover and develop new treatments. It also offers specialized scientific services for validating and inhibiting protein interactions in animal, plant or microbiological cells. Hybrigenics is headquartered in Paris, France.

Hybrigenics SA (ALHYG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 4
List of Figures 4
Hybrigenics SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Hybrigenics SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Hybrigenics SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Hybrigenics SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Hybrigenics SA, Medical Devices Deals, 2012 to YTD 2018 9
Hybrigenics SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Hybrigenics SA, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Hybrigenics Acquires Genomic Division Of Imaxio 11
Equity Offering 12
Hybrigenics Raises USD7.8 Million in Rights Offering of Shares 12
Hybrigenics Raises USD7.1 Million in Public Offering 13
Hybrigenics Raises USD2.7 Million in Private Placement 14
Hybrigenics to Raise USD7.6 Million in Rights Offering of Shares 15
Hybrigenics Raises USD6 Million in Private Placement of Shares 16
Hybrigenics Completes Private Placement Of Shares For US$8.4 Million 17
Hybrigenics Completes Private Placement Of Shares For US$4.1 Million 18
Hybrigenics Completes Second Tranche Private Placement Of Shares For US$1.9 Million 19
Hybrigenics SA - Key Competitors 20
Hybrigenics SA - Key Employees 21
Hybrigenics SA - Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Financial Announcements 23
Apr 26, 2018: Hybrigenics Announces Its Full Year 2017 Results 23
Apr 28, 2017: Hybrigenics fuLL year 2016 resuLts 24
Product News 25
03/26/2018: Hybrigenics broad spectrum inhibitor of Ubiquitin-Specific Proteases shows antiviral activity against human adenoviruses 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List Of Tables

List of Tables
Hybrigenics SA, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Hybrigenics SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Hybrigenics SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Hybrigenics SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Hybrigenics SA, Deals By Therapy Area, 2012 to YTD 2018 8
Hybrigenics SA, Medical Devices Deals, 2012 to YTD 2018 9
Hybrigenics SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Hybrigenics Acquires Genomic Division Of Imaxio 11
Hybrigenics Raises USD7.8 Million in Rights Offering of Shares 12
Hybrigenics Raises USD7.1 Million in Public Offering 13
Hybrigenics Raises USD2.7 Million in Private Placement 14
Hybrigenics to Raise USD7.6 Million in Rights Offering of Shares 15
Hybrigenics Raises USD6 Million in Private Placement of Shares 16
Hybrigenics Completes Private Placement Of Shares For US$8.4 Million 17
Hybrigenics Completes Private Placement Of Shares For US$4.1 Million 18
Hybrigenics Completes Second Tranche Private Placement Of Shares For US$1.9 Million 19
Hybrigenics SA, Key Competitors 20
Hybrigenics SA, Key Employees 21
Hybrigenics SA, Subsidiaries 22

List Of Figures

List of Figures
Hybrigenics SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Hybrigenics SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Hybrigenics SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Hybrigenics SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Hybrigenics SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Hybrigenics SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Hybrigenics SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Hybrigenics SA, Medical Devices Deals, 2012 to YTD 2018 9

Hybrigenics SA (ALHYG) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Hybrigenics SA (Hybrigenics) is a biopharmaceutical company that develops new targets and therapies against proliferative and non-cancerous diseases. Its lead product candidate Inecalcitol, is a vitamin D receptor agonist being

USD 250 View Report

Hybrigenics SA Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

Hybrigenics SA Company Profile is a detailed strategic and analytical report on Hybrigenics SA. The 2018 version of the report offers detailed insights into the companys strategies, developments, outlook and

USD 200 View Report

Hybrigenics SA Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

Hybrigenics SA Company Profile is a detailed strategic and analytical report on Hybrigenics SA. The 2018 version of the report offers detailed insights into the companys strategies, developments, outlook and

USD 200 View Report

Hybrigenics SA (ALHYG) - Financial and Strategic SWOT Analysis Review

Hybrigenics SA (ALHYG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by GlobalData

USD 125 View Report

Your are not allow to send sample request

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available